Year archive

STARPHARMA HOLDINGS LIMITED — 2012 filings

All 69 regulatory filings released by STARPHARMA HOLDINGS LIMITED (SPL) in 2012, sourced directly from the official regulator.

69 Filings

2012 Period

2012 filings (69)

Filing	Released	Lang
Shareholder Update December 2012 4 pages 1.8MB Management Reports	2012-12-18	English
Starpharma appoints experienced Business Development VP 2 pages 99.1KB Board/Management Information	2012-12-16	English
Appendix 3B 9 pages 94.3KB Capital/Financing Update	2012-12-16	English
Change of Director's Interest Notice - J Fairley 2 pages 39.8KB Director's Dealing	2012-12-16	English
Change of Director's Interest Notice - Peter Bartels 2 pages 75.6KB Director's Dealing	2012-12-12	English
Form604 Notice of change of interests of substantial holder 4 pages 63.5KB Major Shareholding Notification	2012-12-10	English
Change of Director's Interest Notice - Jackie Fairley 2 pages 75.4KB Director's Dealing	2012-12-10	English
Change of Director's Interest Notice - Richard Hazleton 2 pages 75.7KB Director's Dealing	2012-12-10	English
Change of Director's Interest Notice 2 pages 75.7KB Director's Dealing	2012-12-09	English
Change of Director's Interest Notice 3 pages 42.8KB Director's Dealing	2012-12-06	English
SPL docetaxel superior to Taxotere across multiple cancers 3 pages 168.0KB Regulatory Filings	2012-12-05	English
Final Director's Interest Notice 2 pages 63.0KB Director's Dealing	2012-12-02	English
Change of Directors Interest Notice 2 pages 74.5KB Director's Dealing	2012-12-02	English
AGM Chair address and CEO presentation 28 pages 2.0MB AGM Information	2012-11-29	English
Results of Meeting 2 pages 38.3KB Declaration of Voting Results & Voting Rights Announcements	2012-11-29	English
Resignation of Director Mr Ross Dobinson 2 pages 98.5KB Board/Management Information	2012-11-28	English
Trading Halt 2 pages 120.2KB Regulatory Filings	2012-11-27	English
VivaGel phase 3 study results 9 pages 165.0KB Regulatory Filings	2012-11-27	English
Phase 3 study results - investor conference calls 2 pages 83.5KB Regulatory Filings	2012-11-27	English
Form604 Notice of change of interests of substantial holder 6 pages 72.8KB Major Shareholding Notification	2012-11-22	English
Starpharma to recoup $6 million cash for overseas R&D 2 pages 99.3KB Capital/Financing Update	2012-11-21	English
Starpharma awarded Janssen 2012 Company of the Year award 3 pages 92.4KB Regulatory Filings	2012-10-31	English
Starpharma presenting at Bell Potter LifeScience Conference 27 pages 2.5MB Investor Presentation	2012-10-31	English
Appendix 4C - quarterly 5 pages 243.5KB Interim / Quarterly Report Q1 2013	2012-10-30	English
New formulations show further improvement in crop protection 3 pages 268.8KB Regulatory Filings	2012-10-29	English
Starpharma's docetaxel demonstrates targeted tumour delivery 3 pages 365.2KB Regulatory Filings	2012-10-28	English
Notice of Annual General Meeting/Proxy Form 15 pages 616.5KB AGM Information	2012-10-21	English
VivaGel BV Phase 3 trials - recruitment complete 2 pages 125.8KB Regulatory Filings	2012-10-17	English
Appendix 3B 8 pages 70.0KB Share Issue/Capital Change	2012-10-04	English
Change of Director's Interest Notice 2 pages 31.2KB Director's Dealing	2012-10-04	English
Date of Annual General Meeting 2 pages 118.3KB AGM Information	2012-09-26	English
Appendix 3B 8 pages 64.8KB Capital/Financing Update	2012-09-17	English
Appendix 3B 8 pages 73.7KB Share Issue/Capital Change	2012-09-12	English
Starpharma signs cancer drug agreement with AstraZeneca 2 pages 115.5KB Regulatory Filings	2012-09-05	English
Annual Report and full year financial results 81 pages 1.6MB Annual Report FY 2012	2012-08-26	English
Appendix 3B 8 pages 96.1KB Share Issue/Capital Change	2012-08-22	English
Appendix 3B 8 pages 96.1KB Capital/Financing Update	2012-08-12	English
Shareholder Update - August 2012 4 pages 1.2MB Investor Presentation	2012-08-07	English
Appendix 4C - quarterly 5 pages 166.9KB Interim / Quarterly Report Q4 2012	2012-07-29	English
SPL presenting at Nomura Biotech Investment Conference 27 pages 1.5MB Investor Presentation	2012-07-23	English
Appendix 3B 8 pages 96.1KB Capital/Financing Update	2012-07-15	English
Appendix 3B 8 pages 97.0KB Share Issue/Capital Change	2012-07-10	English
FORM 604 CHANGE OF INTERESTS OF SUB HOLDER 4 pages 65.1KB Major Shareholding Notification	2012-07-02	English
Reports rapid advancement of drug delivery program 4 pages 152.0KB Investor Presentation	2012-07-02	English
Full enrolment achieved for BV Phase 2 & first Phase 3 trial 3 pages 162.9KB Regulatory Filings	2012-06-24	English
Starpharma`s VivaGel Phase 3 trials 60% enrolled 3 pages 131.2KB Regulatory Filings	2012-06-03	English
Appendix 4C - quarterly 5 pages 153.1KB Interim / Quarterly Report Q3 2012	2012-04-29	English
Response to an ASX price query 4 pages 139.4KB Regulatory Filings	2012-04-23	English
Change of Director`s Interest Notice 2 pages 29.3KB Director's Dealing	2012-04-23	English
Change of Director`s Interest Notice 2 pages 29.2KB Director's Dealing	2012-04-22	English
Shareholder Update April 2012 4 pages 1.7MB Interim / Quarterly Report H1 2012	2012-04-15	English
Appendix 3B 8 pages 99.7KB Share Issue/Capital Change	2012-04-15	English
FORM 604 CHANGE OF INTERESTS OF SUB HOLDER 6 pages 77.4KB Major Shareholding Notification	2012-03-21	English
SPL Commences pivotal phase 3 VivaGel BV treatment trials 4 pages 194.2KB Regulatory Filings	2012-03-21	English
Initial Director`s Interest Notice 2 pages 108.2KB Director's Dealing	2012-03-12	English
Correction - Initial Director`s Interest Notice 2 pages 107.1KB Director's Dealing	2012-03-12	English
Appendix 3B 8 pages 106.5KB Share Issue/Capital Change	2012-03-12	English
International licensing expert Peter Turvey joins SPL Board 2 pages 125.3KB Board/Management Information	2012-03-08	English
Starpharma presenting at Citi investment conference London 26 pages 1.4MB Investor Presentation	2012-03-05	English
Appendix 3B 8 pages 75.1KB Share Issue/Capital Change	2012-02-28	English
Change of Director`s Interest Notice 3 pages 38.1KB Director's Dealing	2012-02-28	English
Change of Director`s Interest Notice 2 pages 35.3KB Director's Dealing	2012-02-28	English
Half Yearly Report and Accounts 24 pages 655.0KB Interim / Quarterly Report H1 2012	2012-02-19	English
SPL`s dendrimers improve efficacy of docetaxel in animals 4 pages 189.8KB Regulatory Filings	2012-01-31	English
Appendix 4C - quarterly 5 pages 127.4KB Interim / Quarterly Report Q2 2012	2012-01-29	English
Appendix 3B 8 pages 102.5KB Share Issue/Capital Change	2012-01-23	English
Appendix 3B 8 pages 102.7KB Share Issue/Capital Change	2012-01-23	English
Change in substantial holding 2 pages 61.7KB Major Shareholding Notification	2012-01-11	English
SPL receives FDA Special Protocol Assessment for BV Phase 3 2 pages 81.9KB Regulatory Filings	2012-01-10	English

Filings by year

2026 13 filings
2025 30 filings
2024 67 filings
2023 74 filings
2022 58 filings
2021 67 filings
2020 75 filings
2019 59 filings
2018 48 filings
2017 43 filings
2016 52 filings
2015 56 filings
2014 75 filings
2013 55 filings
2012 69 filings
2011 72 filings
2010 63 filings
2009 47 filings
2008 49 filings
2007 52 filings
2006 46 filings
2005 61 filings
2004 41 filings
2003 38 filings
2002 6 filings